In addition, the Ras/MEK/ERK pathway has been identified to be activated in AD pathology, and both phosphorylated ERK1 and ERK2 are implied to be associated with tau phosphorylation in neurons and glia cells [47, 48, 51]. This evidence concerns the gene MAPK1 and Alzheimer disease.